PortfoliosLab logo
Thermo Fisher Scientific Inc. (TMO)
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Company Info

ISIN

US8835561023

CUSIP

883556102

IPO Date

Jan 13, 1978

Highlights

Market Cap

$164.11B

EPS (TTM)

$16.40

PE Ratio

26.32

PEG Ratio

1.60

Total Revenue (TTM)

$42.90B

Gross Profit (TTM)

$17.91B

EBITDA (TTM)

$10.60B

Year Range

$409.85 - $626.49

Target Price

$607.94

Short %

1.05%

Short Ratio

2.22

Share Price Chart


Loading data...

Compare to other instruments

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Performance

Performance Chart

The chart shows the growth of an initial investment of $10,000 in Thermo Fisher Scientific Inc., comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.


0.00%10,000.00%20,000.00%30,000.00%40,000.00%NovemberDecember2025FebruaryMarchApril
26,302.23%
3,153.51%
TMO (Thermo Fisher Scientific Inc.)
Benchmark (^GSPC)

Returns By Period

Thermo Fisher Scientific Inc. had a return of -17.92% year-to-date (YTD) and -25.89% in the last 12 months. Over the past 10 years, Thermo Fisher Scientific Inc. had an annualized return of 13.23%, outperforming the S&P 500 benchmark which had an annualized return of 10.05%.


TMO

YTD

-17.92%

1M

-17.05%

6M

-23.33%

1Y

-25.89%

5Y*

5.63%

10Y*

13.23%

^GSPC (Benchmark)

YTD

-6.75%

1M

-5.05%

6M

-5.60%

1Y

8.15%

5Y*

14.14%

10Y*

10.05%

*Annualized

Monthly Returns

The table below presents the monthly returns of TMO, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
202514.90%-11.51%-5.85%-14.26%-17.92%
20241.54%5.79%2.00%-2.15%-0.13%-2.57%10.91%0.28%0.63%-11.68%-3.05%-1.70%-1.72%
20233.57%-5.01%6.46%-3.73%-8.37%2.68%5.16%1.54%-9.08%-12.13%11.46%7.14%-3.36%
2022-12.88%-6.42%8.64%-6.39%2.65%-4.22%10.15%-8.87%-6.94%1.34%9.00%-1.65%-17.29%
20219.43%-11.70%1.46%3.03%-0.16%7.51%7.05%2.77%3.00%10.81%-0.04%5.48%43.54%
2020-3.60%-7.15%-2.40%18.01%4.34%3.83%14.24%3.63%2.98%7.16%-1.72%0.22%43.72%
20199.78%5.66%5.53%1.36%-3.77%10.07%-5.45%3.38%1.53%3.68%3.96%3.54%45.55%
201818.03%-6.93%-0.94%1.88%-0.99%-0.46%13.22%1.95%2.15%-4.27%6.81%-10.26%18.21%
20178.00%3.47%-2.50%7.64%4.51%1.06%0.61%6.61%1.18%2.45%-0.55%-1.42%35.03%
2016-6.90%-2.17%9.72%1.88%5.21%-2.55%7.50%-4.19%4.62%-7.56%-4.71%0.81%-0.12%
2015-0.06%3.83%3.46%-6.45%3.14%0.22%7.53%-10.15%-2.34%6.95%5.83%2.61%13.75%
20143.40%8.16%-3.34%-5.19%2.55%1.06%2.97%-1.06%1.36%-3.39%9.97%-2.98%13.06%

Risk-Adjusted Performance

Risk-Adjusted Performance Rank

The current rank of TMO is 10, meaning it’s performing worse than 90% of other stocks on our website when it comes to balancing risk and reward. Below is a breakdown of how it compares using common performance measures.


The Risk-Adjusted Performance Rank of TMO is 1010
Overall Rank
The Sharpe Ratio Rank of TMO is 88
Sharpe Ratio Rank
The Sortino Ratio Rank of TMO is 1010
Sortino Ratio Rank
The Omega Ratio Rank of TMO is 1212
Omega Ratio Rank
The Calmar Ratio Rank of TMO is 1414
Calmar Ratio Rank
The Martin Ratio Rank of TMO is 33
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

Risk-Adjusted Performance Indicators

The charts below present risk-adjusted performance metrics for Thermo Fisher Scientific Inc. (TMO) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.


The chart of Sharpe ratio for TMO, currently valued at -0.86, compared to the broader market-2.00-1.000.001.002.003.00
TMO: -0.86
^GSPC: 0.49
The chart of Sortino ratio for TMO, currently valued at -1.19, compared to the broader market-6.00-4.00-2.000.002.004.00
TMO: -1.19
^GSPC: 0.81
The chart of Omega ratio for TMO, currently valued at 0.86, compared to the broader market0.501.001.502.00
TMO: 0.86
^GSPC: 1.12
The chart of Calmar ratio for TMO, currently valued at -0.60, compared to the broader market0.001.002.003.004.005.00
TMO: -0.60
^GSPC: 0.50
The chart of Martin ratio for TMO, currently valued at -1.77, compared to the broader market-10.00-5.000.005.0010.0015.0020.00
TMO: -1.77
^GSPC: 2.07

The current Thermo Fisher Scientific Inc. Sharpe ratio is -0.86. This value is calculated based on the past 1 year of trading data and takes into account price changes and dividends.

Use the chart below to compare the Sharpe ratio of Thermo Fisher Scientific Inc. with the selected benchmark, providing insights into the investment's historical performance in terms of risk-adjusted returns. Go to the Sharpe ratio tool for more fine-grained control over the calculation options.


Rolling 12-month Sharpe Ratio-1.000.001.002.003.00NovemberDecember2025FebruaryMarchApril
-0.86
0.49
TMO (Thermo Fisher Scientific Inc.)
Benchmark (^GSPC)

Dividends

Dividend History

Thermo Fisher Scientific Inc. provided a 0.38% dividend yield over the last twelve months, with an annual payout of $1.60 per share. The company has been increasing its dividends for 12 consecutive years.


0.15%0.20%0.25%0.30%0.35%0.40%0.45%0.50%$0.00$0.50$1.00$1.5020142015201620172018201920202021202220232024
Dividends
Dividend Yield
PeriodTTM20242023202220212020201920182017201620152014
Dividend$1.60$1.56$1.40$1.20$1.04$0.88$0.76$0.68$0.60$0.60$0.60$0.60

Dividend yield

0.38%0.30%0.26%0.22%0.16%0.19%0.23%0.30%0.32%0.43%0.42%0.48%

Monthly Dividends

The table displays the monthly dividend distributions for Thermo Fisher Scientific Inc.. The dividends shown in the table have been adjusted to account for any splits that may have occurred.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
2025$0.00$0.00$0.43$0.00$0.43
2024$0.00$0.00$0.39$0.00$0.00$0.39$0.00$0.00$0.39$0.00$0.00$0.39$1.56
2023$0.00$0.00$0.35$0.00$0.00$0.35$0.00$0.00$0.35$0.00$0.00$0.35$1.40
2022$0.00$0.00$0.30$0.00$0.00$0.30$0.00$0.00$0.30$0.00$0.00$0.30$1.20
2021$0.00$0.00$0.26$0.00$0.00$0.26$0.00$0.00$0.26$0.00$0.00$0.26$1.04
2020$0.00$0.00$0.22$0.00$0.00$0.22$0.00$0.00$0.22$0.00$0.00$0.22$0.88
2019$0.00$0.00$0.19$0.00$0.00$0.19$0.00$0.00$0.19$0.00$0.00$0.19$0.76
2018$0.00$0.00$0.17$0.00$0.00$0.17$0.00$0.00$0.17$0.00$0.00$0.17$0.68
2017$0.00$0.00$0.15$0.00$0.00$0.15$0.00$0.00$0.15$0.00$0.00$0.15$0.60
2016$0.00$0.00$0.15$0.00$0.00$0.15$0.00$0.00$0.15$0.00$0.00$0.15$0.60
2015$0.00$0.00$0.15$0.00$0.00$0.15$0.00$0.00$0.15$0.00$0.00$0.15$0.60
2014$0.15$0.00$0.00$0.15$0.00$0.00$0.15$0.00$0.00$0.15$0.60

Dividend Yield & Payout


Dividend Yield
5.0%10.0%15.0%20.0%25.0%
TMO: 0.4%
Thermo Fisher Scientific Inc. has a dividend yield of 0.38%, which signifies it pays a smaller percentage of its stock price in dividends to its shareholders compared to other companies in the market.
Payout Ratio
200.0%400.0%600.0%800.0%1,000.0%1,200.0%
TMO: 5.9%
Thermo Fisher Scientific Inc. has a payout ratio of 5.92%, which is below the market average. This means Thermo Fisher Scientific Inc. returns a smaller proportion of its earnings to shareholders as dividends, suggesting it retains a higher portion for reinvestment, growth, or debt payment.

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.


-40.00%-30.00%-20.00%-10.00%0.00%NovemberDecember2025FebruaryMarchApril
-35.51%
-10.73%
TMO (Thermo Fisher Scientific Inc.)
Benchmark (^GSPC)

Worst Drawdowns

The table below displays the maximum drawdowns of the Thermo Fisher Scientific Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Thermo Fisher Scientific Inc. was 71.16%, occurring on Apr 15, 1999. Recovery took 1698 trading sessions.

The current Thermo Fisher Scientific Inc. drawdown is 35.51%.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-71.16%Jan 2, 1998323Apr 15, 19991698Jan 13, 20062021
-60.35%Mar 6, 1987165Oct 28, 1987406Jun 7, 1989571
-53.91%Aug 18, 200868Nov 20, 2008626May 18, 2011694
-42.05%Oct 4, 1989259Oct 11, 1990144May 8, 1991403
-36.62%Jan 3, 2022819Apr 8, 2025

Volatility

Volatility Chart

The current Thermo Fisher Scientific Inc. volatility is 15.03%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.


0.00%5.00%10.00%15.00%NovemberDecember2025FebruaryMarchApril
15.03%
14.23%
TMO (Thermo Fisher Scientific Inc.)
Benchmark (^GSPC)

Financials

Financial Performance

The chart below illustrates the trends in the financial health of Thermo Fisher Scientific Inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

Annual
Quarterly

0.0

Valuation

The Valuation section provides an overview of how Thermo Fisher Scientific Inc. is priced in the market compared to other companies in the Diagnostics & Research industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.


PE Ratio
20.040.060.080.0100.0
TMO: 26.3
The chart displays the Price-to-Earnings (P/E) ratio for TMO, comparing it with other companies in the Diagnostics & Research industry. Currently, TMO has a P/E ratio of 26.3. This P/E ratio is in line with the industry average, suggesting the stock may be fairly valued relative to its earnings.
PEG Ratio
1.02.03.04.05.06.0
TMO: 1.6
The chart shows the Price/Earnings to Growth (PEG) ratio for TMO compared to other companies in the Diagnostics & Research industry. TMO currently has a PEG ratio of 1.6. This PEG ratio is close to the industry average, suggesting the stock’s valuation is balanced against its growth outlook.
PS Ratio
2.04.06.08.010.0
TMO: 3.8
This chart shows the Price-to-Sales (P/S) ratio for TMO relative to other companies in the Diagnostics & Research industry. Currently, TMO has a P/S ratio of 3.8. This P/S ratio falls within the average range for the industry, suggesting the stock is fairly valued based on its revenue.
PB Ratio
2.04.06.08.010.0
TMO: 3.3
The chart illustrates the Price-to-Book (P/B) ratio for TMO in comparison with other companies in the Diagnostics & Research industry. Currently, TMO has a P/B value of 3.3. This P/B ratio is in line with the industry average, suggesting the stock is valued fairly in relation to its book value.

Income Statement



TTM
Revenue

Total Revenue

Cost Of Revenue

Gross Profit

Operating Expenses

Selling, General & Admin Expenses

R&D Expenses

Depreciation And Amortization

Total Operating Expenses

Income

Income Before Tax

Operating Income

EBITDA

EBIT

Earnings From Continuing Operations

Net Income

Income Tax Expense

Other Non-Operating Income (Expenses)

Extraordinary Items

Discontinued Operations

Effect Of Accounting Charges

Non Recurring

Minority Interest

Other Items

Interest Income

Interest Expense

Net Interest Income

Values in undefined except per share items